 The antibiotic minocycline is a powerful inhibitor of microglial activation, apparently through blockade of NF-kappa-B nuclear translocation. Minocycline is neuroprotective in mouse models of amyotrophic lateral sclerosis ALS and Huntingtons disease and has been recently shown to stabilize the course of Huntingtons disease in humans over a 2-year period. 